Mary Jeanne Kreek, Methadone Developer, Dies at 84

A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.

Written byAsher Jones
| 2 min read
Mary Jeanne Kreek, heroin, addiction, methadone, drug addiction, The Rockefeller University,

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: Mary Jeanne Kreek
ZACH VEILLEUX

Mary Jeanne Kreek, who studied addictive diseases at the Rockefeller University for more than 50 years, died on March 27 at the age of 84. Her work helped uncover the biology behind addiction and, most notably, led to the successful treatment of heroin addiction with methadone.

“She was a wonderful scientist who made groundbreaking contributions to the field of addiction medicine and to social equity in a way that was before her time,” Sarah Schlesinger, a cellular immunologist and physician at the Rockefeller University, tells The Scientist. Kreek championed the idea that people addicted to drugs should be treated with dignity, not stigmatized, Schlesinger adds. “[She saw] the problems of drug use as a genetic disease to which people had a predilection and needed to be treated for, long before that was a common idea. She was a real pioneer in that way.”

Born in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies